Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
NCT00736749 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2026-04-06
Summary
This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.
Conditions
- Hematopoietic Cell Transplantation Recipient
- Leukemia
- Solid Tumor
Interventions
- PROCEDURE
-
Assessment of Therapy Complications
Complete patient response form and Health Status Update Form
- OTHER
-
Questionnaire Administration
Complete patient response form, Health Status Update Form (called the "Keep in Touch" form), and Quality of Life Questionnaire (PROMIS)
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Children's Oncology Group
lead NETWORK
Principal Investigators
-
Smita Bhatia · Children's Oncology Group
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-07-17
- Primary Completion
- 2100-01-31
Countries
- United States
- Puerto Rico
Study Locations
More Related Trials
-
Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
NCT00003217 ·Status: COMPLETED ·Phase: PHASE1
-
Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
NCT00042796 ·Status: TERMINATED ·Phase: PHASE1
-
Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia
NCT00003729 ·Status: TERMINATED ·Phase: PHASE2
-
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
NCT02847130 ·Status: COMPLETED
-
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma
NCT03178617 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
NCT00003650 ·Status: COMPLETED ·Phase: PHASE3
-
Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
NCT00057811 ·Status: COMPLETED ·Phase: PHASE2
-
Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia
NCT00085176 ·Status: COMPLETED
-
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
NCT00002812 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
NCT00003273 ·Status: WITHDRAWN ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma
NCT00002738 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
NCT00006462 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00557193 ·Status: COMPLETED ·Phase: PHASE3
-
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
NCT03834961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
NCT00003671 ·Status: COMPLETED ·Phase: PHASE2
-
SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors
NCT00015899 ·Status: COMPLETED ·Phase: PHASE1
-
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
NCT02176967 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors
NCT00003750 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT02303821 ·Status: COMPLETED ·Phase: PHASE1
-
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
NCT01117441 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
NCT05761171 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Treatment of Acute Lymphoblastic Leukemia in Children
NCT00165178 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
NCT00003735 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia
NCT00002785 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
NCT00005585 ·Status: COMPLETED ·Phase: PHASE3